CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Operating activities:
Net income	$ 309.1	$ 316.2	$ 376.3
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization expense	222.0	218.5	213.8
Impairment of long-lived assets	52.4	53.3
Deferred income tax benefit	(0.5)	(17.1)	(18.2)
Gain on sales of property, plant and equipment	(1.2)	(2.2)	(12.9)
Stock-based compensation expense	24.4	21.3	22.8
Other	7.7	9.8	(4.9)
Changes in operating assets and liabilities (excluding effect of businesses acquired):
Accounts receivable	(31.2)	222.5	(97.2)
Inventories	(30.4)	306.8	(131.0)
Prepaid expenses and other assets	26.7	(25.2)	31.5
Accounts payable and other liabilities	47.5	(78.9)	(24.2)
Net cash provided by operating activities	626.5	1,025.0	356.0
Investing activities:
Purchases of property, plant and equipment	(154.9)	(172.2)	(190.4)
Acquisitions, net of cash acquired	(348.7)	(0.4)	(208.2)
Proceeds from sale of business, net			26.2
Other	(1.5)	2.7	7.4
Net cash used in investing activities	(505.1)	(169.9)	(365.0)
Financing activities:
Net short-term debt (repayments) borrowings	(12.6)	12.7	1.7
Proceeds from long-term debt borrowings	2,073.0	573.0	719.0
Principal payments on long-term debt	(2,061.4)	(962.3)	(552.2)
Debt issuance costs	(6.8)
Dividends and dividend equivalents paid	(120.4)	(120.1)	(108.7)
Exercise of stock options	37.5	15.1	28.8
Share repurchases		(355.5)	(50.0)
Other	(9.5)	(11.4)	(5.6)
Net cash (used in) provided by financing activities	(100.2)	(848.5)	33.0
Effect of exchange rate changes on cash	(2.7)	(8.5)	(1.4)
Increase (decrease) in cash and cash equivalents	18.5	(1.9)	22.6
Cash and cash equivalents at beginning of year	104.3	106.2	83.6
Cash and cash equivalents at end of year	122.8	104.3	106.2
Supplemental cash flow information:
Interest paid during the year	81.4	82.0	82.4
Income taxes paid during the year, net	95.1	$ 204.9	134.2
Non-cash investing and financing activities:
Debt assumed in connection with acquisitions	$ 6.1		$ 39.2